SCHEMBL7814717

SCHEMBL7814717

COc1cc2n[c]n(C)c2cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRD4 O60885 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NQO2 P16083 7/20 0.33
CYP19A1 P11511 2/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
G6PD P11413 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
PDE10A Q9Y233 1/20 0.32
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812397 0.93 NQO2 (0.36) LMNAMEN1KMT2ATSHRHTT
SCHEMBL5982809 0.87 FGFR1 (0.39) LMNAMEN1KMT2ATSHRL3MBTL1
SCHEMBL7814442 0.81 MEN1 (0.41) LMNAMEN1KMT2ATSHRL3MBTL1
SCHEMBL5981558 0.81 KDM4E (0.40) LMNAMEN1KMT2ATSHRHTT
SCHEMBL7815203 0.73 CD44 (0.34) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL16103838 0.70 LMNA (0.51) LMNABRD4SMN1; SMN2MAPTNPC1
SCHEMBL7815337 0.70 ALDH1A1 (0.43) LMNAMEN1KMT2AHTTL3MBTL1
SCHEMBL3652546 0.70 TDP1 (0.44) LMNAMEN1KMT2AHTTL3MBTL1
SCHEMBL5982758 0.70 PTPN1 (0.40) LMNAMEN1KMT2AHTTMAPT
SCHEMBL7818577 0.68 EGLN1 (0.37) LMNATSHRHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed